Metabolomics to unveil and understand phenotypic diversity between pathogen populations.
Leishmaniasis is a debilitating disease caused by the parasite Leishmania. There is extensive clinical polymorphism, including variable responsiveness to treatment. We study Leishmania donovani parasites isolated from visceral leishmaniasis patients in Nepal that responded differently to antimonial...
Main Authors: | Ruben t'Kindt, Richard A Scheltema, Andris Jankevics, Kirstyn Brunker, Suman Rijal, Jean-Claude Dujardin, Rainer Breitling, David G Watson, Graham H Coombs, Saskia Decuypere |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC2994915?pdf=render |
Similar Items
-
Metabolomics for Secondary Metabolite Research
by: Eriko Takano, et al.
Published: (2013-11-01) -
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
by: Saskia Decuypere, et al.
Published: (2012-01-01) -
LC-MS metabolomics from study design to data-analysis – using a versatile pathogen as a test case
by: Maya Berg, et al.
Published: (2013-01-01) -
LC-MS METABOLOMICS FROM STUDY DESIGN TO DATA-ANALYSIS – USING A VERSATILE PATHOGEN AS A TEST CASE
by: Maya Berg, et al.
Published: (2013-01-01) -
Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden.
by: Manu Vanaerschot, et al.
Published: (2011-01-01)